CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Novo Nordisk A/S - share repurchase programme

Neutral
AI Analysis

Summary

Novo Nordisk initiated a share repurchase programme for up to DKK 15 billion over a 12-month period beginning February 4, 2026, in accordance with MAR regulations and Safe Harbour Rules.

Importance:2/10
Sentiment:
0.00
share repurchasecapital allocationbuyback programme
Related Companies

Read the original article

Published by GlobeNewswire Pharma on July 13, 2026 12:24 PM

Read Original